SB140 - TO MANDATE THE USE OF BIOSIMILAR MEDICINES UNDER HEALTH BENEFIT PLANS; TO REQUIRE A HEALTHCARE PROVIDER TO PRESCRIBE BIOSIMILAR MEDICINES; AND TO IMPROVE ACCESS TO BIOSIMILAR MEDICINES.
Bill Status History
Chamber
Date
Action
Vote
Senate
4/1/2025 8:43:13 AM
Recommended for study in the Interim Committee on INSURANCE & COMMERCE - SENATE
Senate
4/1/2025 8:43:02 AM
Withdrawn from Committee and placed on calendar.
Senate
3/10/2025 1:35:47 PM
Re-referred to INSURANCE & COMMERCE - SENATE
Senate
3/10/2025 1:35:35 PM
REPORTED CORRECTLY ENGROSSED
Senate
3/10/2025 7:59:46 AM
Amendment # 2 read the first time, rules suspended, read the second time and adopted, ordered engrossed.
Senate
3/10/2025 7:59:37 AM
Withdrawn from Committee and placed on 2nd reading for purpose of amendment # 2
Senate
2/5/2025 1:37:46 PM
Re-referred to INSURANCE & COMMERCE - SENATE
Senate
2/5/2025 1:37:34 PM
REPORTED CORRECTLY ENGROSSED
Senate
2/5/2025 8:01:35 AM
Amendment # 1 read the first time, rules suspended, read the second time and adopted, ordered engrossed.
Senate
2/5/2025 8:01:27 AM
Withdrawn from Committee and placed on 2nd reading for purpose of amendment # 1
Senate
1/29/2025 1:41:59 PM
Read first time, rules suspended, read second time, referred to INSURANCE & COMMERCE - SENATE
Senate
1/29/2025 9:51:58 AM
Filed
Amendments
Chamber
No.
Sponsor
Introduction Date
Document